Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Sell
37
BEAM Quote, Financials, Valuation and Earnings
Last price:
$20.45
Seasonality move
:
-4.64%
Day range:
$19.66 - $20.51
52-week range:
$13.53 - $35.25
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
26.48x
P/B ratio:
1.80x
Volume:
2.1M
Avg. volume:
2.2M
1-year change:
-26.46%
Market cap:
$2B
Revenue:
$63.5M
EPS (TTM):
-$4.61
BEAM Analysts' Consensus Rating
The 13 analysts providing 12-month price projections for Beam Therapeutics shares anticipate an average target of $44.07, ranging from a low estimate of $20.00 to a high estimate of $80.00. This average target implies a growth of 119.57% compared to the current stock price of $20.07.
Consensus Price Target
$44.07
Highest Price Target
$80.00
Lowest Price Target
$20.00
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Analyst Ratings
| 6M Ago | 1M Ago | Current | |
|---|---|---|---|
| Buy | 8 | 10 | 10 |
| Hold | 6 | 3 | 3 |
| Sell | 0 | 0 | 0 |
| Consensus | Buy | Buy | Buy |
BEAM Recommendation Trends
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
70
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 58x
Buy
62
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
82
SBET alert for Jul 17
SharpLink Gaming [SBET] is down 2.6% over the past day.
Buy
89
EXOD alert for Jul 17
Exodus Movement [EXOD] is down 4.14% over the past day.
Buy
60
U alert for Jul 17
Unity Software [U] is up 7.51% over the past day.
